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In a group of 1066 heroin addicts, who were seeking treatment for opioid agonist treatment,
we looked for differences in historical, demographic, and clinical characteristics, between
patients with different levels of awareness of illness (insight). The results showed that,
in the cohort studied, a majority of subjects lacked insight into their heroin-use behavior.
Compared with the impaired-insight group, those who possessed insight into their illness
showed significantly greater awareness of past social, somatic, and psychopathological
impairments, and had a greater number of past treatment-seeking events for heroin addic-
tion. In contrast with other psychiatric illnesses, the presence of awareness appears to
be related to the passing of time and to the worsening of the illness. Methodologies to
improve the insight of patients should, therefore, be targeted more directly on patients
early in their history of heroin dependence, because the risk of lack of insight is greatest
during this period.
Keywords: awareness of illness, compliance to treatment, heroin addiction, insight, mental status, natural history
of addiction, psychiatry, severity of illness
INTRODUCTION
Patients’ lack of insight into their mental illness is a complex
and poorly investigated phenomenon which seriously influences
psychosocial functioning, shows a clear correlation with the sever-
ity of psychiatric symptoms, and has been seen as related to
treatment compliance, with important prognostic implications
(Husted, 1999; Francis and Penn, 2001; Vender and Poloni, 2006).
In psychology and psychiatry, insight can mean the ability to
recognize one’s own mental illness (Markova, 2005). Insight is also
defined as awareness of mental illness. The interchangeability of
these two terms derives directly from the definition of “insight,”
and is widely supported by the current literature: in the validation
process of several questionnaires designed to measure patients’
insight into mental illness, insight has been defined as “self-
appraisal of Illness” (Marks et al., 2000), “judgment” (Kokoszka
et al., 2008), “self-reflection on patients’ anomalous experiences”
(Engh et al., 2007), “awareness of having a mental disorder” (Beck
et al., 2004), and “awareness of psychiatric illness” (Roncone et al.,
2003). Special attention has been paid to three different elements
that are involved: insufficient awareness in patients of specific
aspects of each form of the disease, the neurocognitive impair-
ment entailed in each case, and consequent failures to comply
with treatment.
An impaired level of insight has been suggested in psychiatry.
With reference to mood disorders, patients’awareness of illness has
been shown to be related to the polarity of mood episode (poorer
insight in mania if compared with mixed states and depression),
and to the type of bipolar disorder (poorer insight in bipolar II
stabilized patients, if compared with bipolar I stabilized patients;
Pallanti et al., 1999; Dell’Osso et al., 2002; Varga et al., 2006). With
reference to anxiety disorders, they have shown higher levels of
insight if compared with mood disorders (Ghaemi et al., 2000).
In psychotic disorders, a poor degree of insight has been associ-
ated with a poorer course of the illness and non-compliance with
treatment that is necessary for patients (Husted, 1999). Unexpect-
edly, deficits in insight have not been found to be more common
and severe in patients with schizophrenia than in those with
bipolar disorder – a finding that has strong clinical, theoreti-
cal, and nosological implications (Pini et al., 2001). In the case
of the obsessive-compulsive disorder, which is typically charac-
terized by an excellent level of insight, a trend toward a lower
level of insight has been noted in patients with somatic obses-
sions and in obsessive-bipolar patients (Marazziti et al., 2002). In
post-traumatic stress disorder as well has been shown the need
to improve awareness of illness to better understand the disease
and the possible complications that it could occur (Khoury et al.,
2010).
An impaired level of insight has been suggested and sometimes
explored in Substance Use Disorders (SUD), too.
Substance abusers usually deny, or lack awareness of, their prob-
lem. Recent neuroscientific evidence suggests that the denial of
problems related to drug use may be associated with alterations
in various brain networks that contribute to insight. This inte-
grated model includes the insula, which is involved in introception,
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self-awareness, and drug craving; the anterior cingulate, which is
involved in behavioral monitoring and response selection; and
the frontal and dorsal striatum, which is involved in automatic
habit formation and self-awareness (Verdejo-Garcia and Perez-
Garcia, 2008; Goldstein et al., 2009). Of particular interest is the
role played by the insula in processes related to conscious intro-
ception, emotional experience, and decision-making. Within this
framework the insula contributes to the way addicted individuals
feel, remember, and decide about taking drugs – the main result
being that drug addiction turns out to be like a naturally moti-
vated behavior, closely comparable with eating and sex (Naqvi
and Bechara, 2010).
As to alcohol, a close relationship has been observed between
the state of patients’ insight and their level of motivation to change
their own behavior (Jung et al., 2011). Some papers have pointed
out the effect of insight on patients’ willingness to change their
lifestyle, suggesting the need for brief insight-enhancement inter-
ventions addressed to patients with alcohol dependence (Kim
et al., 2007). When a contemporary mental illness is present (in
cases with dual diagnosis), this has been hypothesized to act
as a fundamental factor in impairing insight level (Yen et al.,
2009).
A few studies have been dedicated to investigating the role
of insight in cocaine dependence. Some authors have examined
the potential association between awareness of illness and drug-
seeking behavior, and have gone on to propose, especially with
cocaine subjects who are urine-negative, interventions to enhance
insight, in order to improve their longer-term clinical outcomes
(Moeller et al., 2010). Active cocaine abusers display a diminished
neural response to errors, with particular reference to the anterior
cingulate cortex, which is closely involved in error processing. The
inability to detect or adjust performance in response to errors has
been linked with clinical symptoms, including the loss of insight
and perseverative behavior. According to this theory, behavioral
deficits that probably contribute to the maintenance of drug
dependence could derive directly from a cognitive dysfunction
(Hester et al., 2007).
With reference to cannabis, there has been a great deal of debate
over the role of THC in the pathogenesis of psychotic disor-
ders; to date, cannabis use has been considered to be one of the
most important risk factors for psychosis (Sevy et al., 2010; Hall
and Degenhardt, 2011; Kuepper et al., 2011; Large et al., 2011).
Whatever the cause, it is very difficult for many subjects to bring
cannabis use to a stop during the early phases of recovery, not
only because of prior habits of use, but also because of the atten-
dant psychotic symptoms, including poor insight and judgment,
lack of impulse control, and, most crucially, cognitive impairment.
Moreover, most of these subjects are unable to grasp the fact that
cannabis use is connected with the onset of symptoms. Of course,
patients’ insight is a basic condition for understanding the need
for treatment programs, and is still further damaged by on-going
substance use (Miller et al., 2005).
In the field of heroin addiction, there is, in the literature, a
worrying and unjustified shortage of data. This fact is even more
disquieting when it is borne in mind that heroin addicts often fail
to comply with methadone treatment when this is prescribed at
appropriate blocking dosages. Lack of insight is a very difficult state
for building the motivation that is indispensable for compliance
or abstinence.
In our opinion medicine and, especially, addiction medicine
can no longer be conceived as a simple intervention whose results
depend exclusively on a physician’s decision. Patients have, in fact,
become ever more closely involved in the therapeutic process, espe-
cially on rehabilitative grounds, so that they actually take part
in their treatment, though not at a decision-making level (Fal-
loon, 1988). Increasing efforts have been dedicated to informing
and educating patients and significant ones about health issues,
so making possible the active participation of any concerned
citizen (Falloon, 1988, 1995; Falloon and Fadden, 1995). Thus,
on rehabilitation and prevention grounds, it is crucial to pro-
vide information about the nature of the disease, its features
and its course, while making clear which of the available treat-
ments are the most effective (Anderson et al., 1986; Falloon, 1988;
Bellack and Mueser, 1993), and overcoming misleading thinking
styles.
We assume that a patient’s compliance with therapy is to
some degree related to his/her insight. As a result, the assess-
ment of insight is necessarily preliminary to an educational
process that improves the patient’s active role in the therapeu-
tic process. Correlations between the patient’s degree of insight
and the history of addiction may be helpful to clinicians in
identifying which patients are most in need of an educational
intervention.
On the basis of these observations, a cohort study was designed
with the aim of correlating the presence-absence of insight with
the history of heroin addiction of patients entering opioid agonist
treatment (AOT). It is, in fact, a key priority to be able to highlight
the clinical features of patients without insight, because that ability
makes it easy to select patients who need to be helped to develop
their insights.
Study data were obtained from a general database of patients
enrolled during the years 1994–2011 at the Vincent P. Dole Dual
Diagnosis Unit, Santa Chiara University Hospital, Department of
Psychiatry, University of Pisa, Italy. We selected patients whose
awareness of illness data had already been obtained. This is,
therefore, a retrospective, observational, cross-sectional study of
heroin-dependent people at treatment entry.
MATERIALS AND METHODS
SETTING
The program in which our patients are placed after a starting evalu-
ation, is characterized by a high threshold program. We believe that
patients with better insight will best benefit from this type of pro-
gram. All these considerations aroused the interest of our research
group in the degree of insight of heroin-dependent patients as
a feature to be included in any program that relies on opioid
agonists. We believe we need to study patients’ insight before
admission into methadone treatment (MMT). In our view stable
methadone maintenance should be considered a good outcome.
It is highly likely that a heroin user on stable MMT may think
he/she has no problems and be given a score indicative of that user
being “without insight” just because there is no problem in his/her
life. We think that this bias may be “controlled,” by interviewing
patients before treatment.
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Subjects
The sample consisted of 1066 heroin-dependent patients (accord-
ing to DSM III/IIIR/IV/IVR criteria); of these, 810 (76.0%) were
males and 256 (24.0%) females. The average age was 29± 6 years
old (range 16–51). Most of the patients were single (N = 681;
64.0%), had fewer than 8 years of education (N = 750; 70.5%),
and were unemployed (N = 421; 39.5%).
Compared with females, males were older (T = 4.06; p =<
0.001) more often single (χ2= 21.2; df 1; p=<0.001) and blue-
collar workers (χ2= 25.4; df 3; p< 0.001). By contrast, females
were more often students and unemployed. No differences were
observed as regards education, income, type of housing, place
of birth or residence, or on the question of whether they were
receiving public welfare benefits.
We selected patients that were coded 0 on the Drug Addiction
History Questionnaire (DAH-Q, see below) for item 7 (classified
as “without-insight patients,” n= 690). In the DAH-Q, the pres-
ence/absence of insight is related to the correctness of the patient’s
knowledge about the nature of the disease with respect to its patho-
genesis, prognosis, and treatment modalities (see Instruments).
For our comparison group we selected patients coded 1 (partial or
total insight, classified as “with-insight patients,” n= 376). These
two groups were then compared for demographic, toxicological,
psychopathological, and treatment-related variables.
All patients gave their informed consent to the anonymous use
of their personal clinical data records for research purposes.
Instruments
Insight assessment. We started to collect data on awareness of
illness of our heroin-dependent patients in 1994. We developed
this interview on the basis of the different aspects that, in the lit-
erature, are considered to be involved in determining a patient’s
level of insight. Several instruments in the last decade have been
developed to allow the measurement of awareness of illness in
psychiatric patients, but they have mainly been validated in psy-
chotic and bipolar patients (Marks et al., 2000; Roncone et al.,
2003; Beck et al., 2004; Markova, 2005; Engh et al., 2007; Cam-
prubi et al., 2008; Kokoszka et al., 2008). Only one instrument, to
the best of our knowledge, has been validated in alcoholic patients
(Kim et al., 1998). Moreover, when we started to study insight in
our patients, these instruments had not yet been worked out. Our
clinical interview, therefore, has never been a structured interview.
Our research group has, however, always interpreted the results of
the interview in the same way, and has always encoded interview
results in the same way at DAH-Q. This made possible the selec-
tion of patients without insight in a way incurring a low risk of
false negatives.
Two psychiatrists who had almost 2 years of postgraduate expe-
rience carried out the interview. These two researchers had to
agree on a patient’s lack of insight, and a senior researcher had to
agree, too.
Subjects were asked
• Why they had applied for treatment, and what they would do
if the substance were widely available at zero cost.
• What they think is required to bring about the termination
of heroin use, what being addicted means, what “withdrawal”
means, and why relapse often occurs after apparent remission.
• What they consider to be the most effective way of staying
free of addiction, what objectives must be achieved for any
treatment to be classified as effective, and about their views
on special issues such as treatment in situations comprising
hepatitis, and HIV infection.
• What kinds of professional skill are more or less important for
treatments to be successful. The judgments expressed made
it possible to understand indirectly whether subjects thought
addiction belongs to the psychosocial or the biological sphere.
We considered patients to be without insight when all the
following perceptions were present (code= 0):
• A patient denies having long-term problems with substance
use control; he/she fails to understand the risk of relapsing after
detoxification and/or tends to recognize a state of only par-
tial well-being as amounting to the achievement of definitive
healing;
• He/she is unable to relate the behavioral changes personally
experienced to the chronic intoxication effects brought about
by the substance;
• He/she considers agonist opioid treatment to be useless, and
argues that their ability to recover from the disease is entirely
due to their “willpower”.
On the other hand, we considered patients to be in possession of
partial or total insight if one or more of the above situations were
absent (code= 1). The results of this assessment were reported in
DAH-Q items 7.
For these reasons, we cannot provide evidence of the psycho-
metric properties of the instrument, nor of inter-rater reliability,
because the instrument has changed slightly over the years. How-
ever, the fact that only two categories (patients without insight
and patients with total or partial insight) were being compared
may have reduced this bias. Control over bias from different raters
was partially ensured by the supervision of a senior psychiatrist
(I. Maremmani), who continued to work at the Psychiatric Clinic
of the University of Pisa for as long as the research lasted and still
works there.
Drug addiction history questionnaire. The DAH-Q (Marem-
mani and Castrogiovanni, 1989) is a multi-dimensional question-
naire that comprises the following eight areas: 1 – demographic
data, 2 – physical health, 3 – mental status, 4 – social adjustment
and environmental factors, 5 – substances abused, 6 – substance
abuse modalities (heroin intake, modality of use, stages of illness,
nosography), 7 – treatment history, and 8 – addiction history (age
at first contact, age at onset of continuous use, dependence length,
and age at first treatment). The questionnaire rates 10 presence-
absence items: 1 – somatic comorbidities, 2 – abnormal mental
status, 3 – work problems, 4 – household problems, 5 – sexual
problems, 6 – socialization and leisure time problems, 7 – drug-
related legal problems, 8 – poly-substance abuse, 9 – previous
treatment, 10 – combined treatments.
We encoded the modality of use as follows: 1 – stables, 2 –
junkies, 3 – two worlders, 4 – loners according to Lahmeyer’s
classification (Lahmeyer et al., 1988). “Stables” are opioid addicts
who espouse conventional values, hold legitimate jobs, are gen-
erally law-abiding and do not associate with other addicts. “Hus-
tlers,” otherwise called “junkies” or “criminal addicts,” are closely
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identified with an addict subculture,are not legitimately employed,
and subsist on the proceeds of criminal activities. “Two-worlder”
addicts engage in criminal activities and associate with other
addicts, but are also legitimately employed. “Loner” addicts are
not involved either in the addict subculture or the conventional
culture. They are usually unemployed, and live on welfare ben-
efits rather than on the proceeds of criminal activities. These
uninvolved addicts may have severe psychological disorders.
Their development of addiction may be considered to consist
of three stages: 1 – acute (immediate) drug effects (Honeymoon
Stage); 2 – transition from recreational use to patterns of use con-
sistent with addiction (Increasing Dose Stage); and 3 – end-stage
addiction, which is characterized by an overwhelming desire to
obtain the drug, a diminished ability to control drug-seeking and
reduced pleasure from biological rewards (Revolving Door Stage;
Kalivas and Volkow, 2005).
Considering the clinical typology, drug addicts can be divided
into 1 – reactive (presence of psychosocial stressors before using
heroin), 2 – self-therapeutic (presence of psychiatric stressors
before using heroin), and 3 – metabolic (no psychosocial or
psychiatric antecedents; Maremmani and Popovic, 2009).
Psychiatric diagnostic evaluation. Psychiatric disorders were
investigated on the basis of the DSM-IV Decision Trees for Dif-
ferential Diagnosis (APA, 2000). Each decision tree starts with a
set of clinical features. When one of these features is a prominent
item of the current clinical picture, the clinician will ask a series of
questions to rule in or rule out a number of disorders. The ques-
tions are just approximations to the diagnostic criteria that are
used, and are not meant to replace them. Three decision trees have
been used: “Differential Diagnosis of Psychotic Disorders” (initial
clinical features: delusions, hallucinations, disorganized speech, or
grossly disorganized behavior); “Differential Diagnosis of Mood
Disorders” (initial clinical features: depressed, elevated, expan-
sive, or irritable mood; two separate items record the presence
of depression and/or any tendency toward the bipolar spectrum
as testified by an elevated, expansive, or irritable mood); “Dif-
ferential Diagnosis of Anxiety Disorders” (initial clinical features:
symptoms of anxiety, fear, avoidance, or increased arousal).
As to bipolar spectrum diagnoses, histories of previous hypo-
manic episodes, as well as temperamental characteristics, were
explored using the criteria listed in the SID, the Semi-structured
Interview for Depression (Cassano et al., 1989). All information
was gathered from the patient and at least one close relative (usu-
ally from parents or siblings); in addition, all available clinical
records were carefully examined. Inquiries into temperamental
attributes were made about the habitual behavior of the patient –
during periods free of affective episodes – by gathering infor-
mation from the patient and significant others. Although it may
seem strange that such figures have been documented for addicted
patients, Italian addicts find it hard to become detached from their
families, despite the disruption of family relationships. In fact,
almost 90% of the patients in our sample were still living with
their original or acquired families.
Our operational criteria for affective temperaments have been
drawn from the University of Tennessee (Akiskal and Mallya, 1987)
modification of the Schneiderian descriptions (Schneider, 1958).
The SID, developed as part of the Pisa-Memphis (now San Diego)
collaborative study on affective disorders, has been used with over
2000 patients at the time of writing; its reliability for diagnostic
assessment of patients and their temperaments has been docu-
mented elsewhere (Perugi et al., 1990, 1997). The SID was resorted
to with the aim of raising the level of diagnostic accuracy with
respect to bipolar disorders. On the hypothesis that minor bipo-
lar syndromes were overrated, that bias would not affect the rate
of DD. In fact, the relationship between outcome and specific
diagnostic subgroups is beyond the study’s terms of reference.
Patients were evaluated while outside acute phases, for which
hospitalization would often be required, so as to reduce the
diagnostic ambiguity between intoxication-related symptoms and
spontaneous mental disorders. In cases where further information
emerged on clinical grounds or from later interviewing, diagnoses
were reviewed.
When an independent psychiatric disorder is concomitant with
a substance abuse disorder, we consider the patient as being
affected by a dual diagnosis condition.
Data analysis
The two groups selected on the basis of the DAH-RS item 7 score
for the presence/absence of insight were compared for the demo-
graphic and addiction history of each group by means of the
chi-square test for categorical variables, and Student’s t -test for
continuous variables. Variables for which a statistically significant
difference between the two groups was detected (p< 0.05) were
treated (inserted) as independent variables in a logistic regression
analysis with the presence/absence of insight as a binary outcome.
Multiple regression is a general statistical technique through
which one can analyze the relationship between a dependent or
criterion variable and a set of independent or predictor variables.
Multiple regression may be viewed as a descriptive tool that can
“simplify” the prediction equation by deleting independent vari-
ables that do not add substantially to prediction accuracy, once
certain other independent variables are included.
All analyses were carried out using the statistical package of
SPSS (version 20.0). Since this is an exploratory study, statistical
tests were considered significant at the p< 0.05 level.
RESULTS
DEMOGRAPHIC DATA
With respect to demographic data, no differences were observed
regarding age, gender, marital status (single or otherwise), occupa-
tion (student, white-collar, blue-collar, and unemployed), income
(poor or better off), and living situation (alone or otherwise).
Heroin addicts with and without insight significantly differed as
regards education: 66.7% of with-insight heroin addicts had had
over 8 years of education, whereas 72.6% of those without insight
had had fewer than 8 years of education (χ2= 4.06, p= 0.043).
DAH-Q FACTORS AND ADDICTION HISTORY
Table 1 shows differences between heroin addicts with and
without insight regarding DAH-Q factors. No differences were
observed among work, social, and leisure problems. Com-
pared with heroin addicts without insight, with-insight heroin
addicts frequently showed more somatic and psychopathological
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Table 1 | DAH-RS factors and addiction history.
N valid With insight N =376 Without insight N =690 Chi p
N (%) N (%)
Somatic comorbidity 1065 280 (74.5) 460 (66.8) 6.81 0.009
Work major problems 1022 234 (63.4) 415 (63.6) 0.00 0.964
Household major problems 1014 311 (83.4) 428 (66.2) 35.17 <0.001
Parental relationships 1002 245 (67.1) 363 (57.0) 9.99 0.001
Marital/partner relationships 282 169 (68.7) 253 (51.6) 19.50 <0.001
Parental role 402 87 (84.5) 126 (42.1) 55.09 <0.001
Loving major problems 1026 225 (63.7) 356 (54.3) 8.42 0.003
Social and leisure major problems 1055 172 (46.4) 307 (45.2) 0.12 0.721
Legal problems 1057 168 (45.0) 210 (30.7) 21.60 <0.001
Poly-abuse 1062 269 (71.5) 318 (46.2) 63.38 <0.001
First treatment 1066 104 (27.9) 260 (37.8) 10.64 0.001
M ±SD M ±SD T p
No. somatic comorbidities 1065 1.67±1.5 1.33±1.3 −3.61* <0.001
No. psychiatric comorbidities 1066 4.15±2.5 1.73±2.1 −15.80* <0.001
No. abused substances 1062 3.61±1.5 2.53±1.7 −10.25 <0.001
No. different treatments in past 1066 1.79±1.3 1.39±1.5 −5.14* <0.001
Age at first contact (years) 991 18±4 19±4 0.96 0.336
Age at onset of continuous use 979 21±5 21±5 −0.38 0.703
Dependence length (in months) 895 89±68 104±90 −2.28* 0.022
Age at first treatment 973 25±5 26±6 2.21 0.027
*Mann–Whitney U–Wilcoxon rank sum W test.
comorbidity, household major problems (parental relationships,
marital/partner relationship, and parental role), problems in love
relationships, legal problems, poly-abuse, and past unsuccessful
treatments. In addition to heroin, they also abuse a greater number
of substances and had received many different treatments previ-
ously. In summary, the clinical picture of drug addiction observed
was more severe in heroin addicts with than without insight.
Considering variables characterizing drug addiction history, no
differences were found regarding their age of first consumption
and their age of continuous use of heroin. The dependency length
of with-insight patients was shorter and their age at first treatment
younger.
MENTAL STATUS AT TREATMENT ENTRY AND DIAGNOSIS
Regarding patients’ mental status at treatment entry, only the pres-
ence/absence of abnormal consciousness and delusions revealed
no significant differences between the two groups evaluated for
insight. 22.3% of with-insight patients showed memory alter-
ations, as opposed to 7.7% of without-insight patients (χ2= 46.20,
p< 0.001). 54.3% of with-insight patients showed anxiety, against
33.5% of those without insight (χ2= 43.20, p< 0.001). 61.1% of
with-insight patients showed a major depressive episode, against
38.4% of those without insight (χ2= 46.20, p< 0.001). 49.2%
of with-insight patients showed sleep disturbances, against 27.1%
of those without insight (χ2= 52.08, p< 0.001). 25.0% of with-
insight patients showed eating disturbances, as opposed to 11.2%
of those without insight (χ2= 34.49, p< 0.001). 34.7 and 30.8%
of with-insight patients were excited and violent, against 18.6
and 16.3% of without-insight ones, respectively (χ2= 34.22 and
30.32, p< 0.001). 14.8% of with-insight patients reported sui-
cidal ideation, as opposed to 6.0% of those without insight
(χ2= 22.75,p< 0.001). 7.5% of with-insight patients showed hal-
lucinations, against 3.1% of those without insight (χ2= 10.85,
p< 0.001). In summary, patients with-insight more frequently
show an abnormal mental status upon entering treatment.
Table 2 shows differences between heroin addicts with and
without insight as regards diagnoses. With-insight patients were
more frequently diagnosed as dual diagnosis patients. In particular,
they were diagnosed as having recurrent depression and bipolar
spectrum disorders.
LIFETIME REPORTED CONCOMITANT ABUSE OF SUBSTANCES
With respect to lifetime self-reported concomitant substance abuse
at treatment entry, with-insight patients used more alcohol fre-
quently than without-insight ones (41.8 vs. 30.2%, χ2= 14.43,
p< 0.001), CNS depressants (36.2 vs. 23.3%, χ2= 19.92,
p< 0.001), CNS stimulants (60.4 vs. 36.7%, χ2= 54.93), hallu-
cinogens (41.1 vs. 21.8%, χ2= 44.09, p< 0.001), cannabinoids
(79.0 vs. 54.3%, χ2= 63.48, p< 0.001), illegal methadone (36.3
vs. 18.7%, χ2= 39.70, p< 0.001). Only the concomitant use of
inhalants revealed no significant differences.
HEROIN (AB)USE MODALITIES
Table 3 shows the differences between heroin addicts with and
without insight regarding their abuse modalities. Heroin addicts
with-insight more frequently demonstrated the following charac-
teristics: multi-daily heroin intake, junkie and two worlder modal-
ities of heroin use located in the intermediate or “dose-increasing”
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Table 2 | Diagnoses.
N valid With insight N =376 Without insight N =690 Chi (df) p
N (%) N (%)
With psychiatric comorbidity 569
Chronic psychosis 40 (10.6) 49 (7.1)
Depression, recurrent 107 (28.5)* 154 (22.3)*
Bipolar spectrum 81 (21.5)* 64 (9.3)*
Anxiety disorders 27 (7.2) 47 (6.8)
Without psychiatric comorbidity 497 121 (32.2)* 376 (54.4)* 60.35 (3) <0.001
Dual diagnosis 1066 255 (67.8) 314 (45.5) 48.68 (1) <0.001
*p<0.05.
Table 3 | Abuse modalities.
N valid With insight N =376 Without insight N =690 Chi p
N (%) N (%)
Heroin intake 965
Sporadic 44 (12.5) 90 (14.7)
Weekly 10 (2.8) 19 (3.1)
Multi-weekly 41 (11.6)* 31 (5.1)*
Daily 81 (22.9)* 273 (44.6)*
Multi-daily 177 (50.1)* 199 (32.5)* 60.21 <0.001
Modality of use 990
Stables 164 (45.3)* 402 (64.0)*
Junkies 110 (30.4)* 116 (18.5)*
Two worlders 72 (19.9)* 71 (11.3)*
Loners 16 (4.4) 39 (6.2) 41.37 <0.001
Periodic self-detoxification 950 263 (74.9) 463 (77.2) 0.61 0.433
Stages of heroin addiction 946
Encounter or honeymoon 29 (8.1) 44 (7.5)
Intermediate or dose-increasing 94 (26.4)* 96 (16.3)*
Repeated detoxification or revolving door 233 (65.4)* 450 (76.3)* 15.08 <0.001
Clinical typology 935
Reactive (psychosocial antecedents) 43 (12.3) 70 (12.0)
Self-therapeutic (psychiatric antecedents) 86 (24.6)* 106 (18.1)*
Metabolic (no psychosocial or psychiatric antecedents) 221 (63.1)* 409 (69.9)* 5.94 0.051
Past treatments 1060 269 (72.1) 427 (62.2) 10.64 0.001
*p<0.05.
phase of illness, having psychiatric antecedents before heroin use
and having been treated previously without success. They were
more frequently diagnosed as dual diagnosis patients. Conversely,
without-insight patients showed the following characteristics:
daily heroin use, stable modality of use, being in the “revolv-
ing door” phase of illness, having no psychosocial or psychiatric
antecedents prior to heroin use.
PREVIOUS AND CONCOMITANT TREATMENTS
With respect to previous treatments the with-insight patients have
been treated more frequently with short-term methadone than
without-insight ones (46.5 vs. 30.5%, χ2= 26.86, p< 0.0001).
The same occurred for psychotherapy (26.2 vs. 17.3%,χ2= 11.84,
p< 0.0001) and psychopharmacology (31.5 vs. 25.6%, χ2= 4.18,
p= 0.040). With-insight patients have also been treated more fre-
quently in a therapeutic community (32.4 vs. 26.0%, χ2= 4.84,
p= 0.027). No differences between groups were observed
regarding methadone and naltrexone maintenance treatment.
With respect to concomitant treatments, with-insight patients
received more psychopharmacotherapy (26.4 vs. 16.2%,χ2= 15.8,
p< 0.001). No differences were observed as regards psychotherapy
or therapeutic community interventions.
PREDICTORS OF INSIGHT
Table 4 shows the results of the backward logistic regression
including as predictive factors those that proved to be significantly
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Table 4 | Predictors of non-insight.
Predictors B Exp (B) −95% CI +95% CI p
Heroin intake 0.004
Multi-weekly −0.58 0.55 0.32 0.96 0.036
Daily 0.45 1.57 1.10 2.25 0.013
Modality of use 0.001
Junkies −0.85 0.42 0.20 0.87 0.020
Two worlders −0.96 0.37 0.18 0.79 0,010
Poly-abuse: absence 0.58 1.79 1.33 2.42 0.000
Household: satisfactory situation −0.56 0.56 0.42 0.76 0.000
Dual diagnosis: absence 0.56 1.75 1.29 2.37 0.000
Backward logistic regression. Statistics: χ2 =118.57, df 10, p=0.000.
correlated with the presence/absence of insight in heroin addicts
in the univariate analysis. On the basis of this analysis, the odds
of having no insight were higher for patients with daily heroin
intake (OR 1.57), with absence of poly-abuse (OR 1.79) and with
absence of dual diagnosis (OR 1.75). Conversely, the odds of hav-
ing insight were higher for multi-weekly heroin intake (OR 0.55),
junkies (OR 0.42) or two worlders (OR 0.37), heroin addicts, and
heroin addicts with a satisfactory household situation (OR 0.56).
DISCUSSION
In our sample, with-insight heroin addicts present a higher level of
education, appear to show greater severity from a clinical point of
view, present a shorter dependence length and are younger at first
treatment. The presence of insight is associated with impaired
mental status and with a stronger record of lifetime concomi-
tant substance abuse at treatment entry. Insight is also associated
with abuse modalities such as being junkies or two worlders
with a multi-daily and multi-weekly heroin intake. With-insight
patients more frequently than those without insight report previ-
ous short-term methadone treatments, psychotherapy, a concomi-
tant psychopharmacology treatment, and a previous therapeutic
community experience. As to diagnosis, with-insight patients are
more frequently dual diagnosis depressed patients belonging to a
bipolar spectrum. In our sample, being two worlders or junkies,
presenting household major problems, and being dual diagnosis
poly-abusers with a multi-weekly heroin intake, seem to corre-
spond to the highest likelihood of belonging to the with-insight
group of patients.
On the basis of our data the awareness of illness often appears
to be absent in heroin addicts, as happens in a wide range of
psychiatric conditions, too, including mood disorders, psychotic
disorders, and the obsessive-compulsive disorder with a prevalence
of somatic obsessions (Husted, 1999; Pallanti et al., 1999; Pini et al.,
2001; Dell’Osso et al., 2002; Marazziti et al., 2002; Varga et al.,
2006). An impaired level of insight has likewise been reported in
the literature among other substance abusers (alcohol, Kim et al.,
2007; Yen et al., 2009; cocaine, Hester et al., 2007; Moeller et al.,
2010; and cannabis, Miller et al., 2005), in a pattern displaying
similarities and some important differences.
In our sample there is a correlation between insight and a
patient’s educational level. This relationship, to our knowledge,
had been poorly investigated, and is thus difficult to discuss
thoroughly. Despite this, as far as our heroin-dependent patients
are concerned, education seems to promote insight. One very sim-
ple explanation may be that the impaired insight group, who
achieved a lower level of education, might simply have been
unaware that addiction is a disease and are thus led to believe in
willpower by their lack of formal knowledge. This finding strength-
ens the idea that we need to improve the counseling provided to
our heroin addict patients.
From a clinical point of view, with-insight heroin addicts
belonging to our sample appear to display greater severity. Among
alcohol-dependent patients the state of patients’ insight has been
correlated with their level of motivation to change their lifestyle
(Kim et al., 2007; Jung et al., 2011); if that finding is correct, the
same kind of motivation could arise in heroin addicts from a
painful and distressing lifestyle marked by somatic comorbidity,
household, loving and legal problems, poly-abuse, and unsuccess-
ful treatments in the past. Especially multiple substance abuse is
usually correlated with a low insight (Martinotti et al., 2009).
The presence of insight in our heroin addict group was
also associated with impaired mental status, psychopathological
comorbidity, and the presence of a dual diagnosis, with a promi-
nent role played by bipolar spectrum and recurrent depression.
These observations are in open contrast with the literature, as the
presence of a concomitant mental illness has been hypothesized to
be a fundamental factor impairing insight level, both in substance
abuse (alcohol and cannabis; Miller et al., 2005; Yen et al., 2009),
and psychiatric disorders (Husted, 1999; Francis and Penn, 2001;
Vender and Poloni, 2006). In even greater contrast with the litera-
ture is the evidence of a correlation between a preserved awareness
of illness and the datum of belonging to a bipolar spectrum: a
greater relative impairment of insight has, in fact, been observed
in mood vs. anxiety disorders (Ghaemi et al., 2000). Moreover, if
we consider the obsessive-compulsive disorder, which is marked
out by good levels of insight in patients, a trend toward a lower
level of insight has been noted in obsessive-bipolar patients with
a history of repeated manic or hypomanic episodes (Marazziti
et al., 2002). In reality, this observed correlation between insight
and bipolarity cannot be considered surprising, when we con-
sider that bipolar-I patients show higher levels of insight than
bipolar-2 patients (Pallanti et al., 1999). There is no doubt that
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bipolar 1 illness is more severe than bipolar 2, as is demonstrated
by its acute consequences, such as psychosis and hospitalization.
Likewise, bipolar heroin addicts are patients whose condition is
more severe than uncomplicated heroin-dependent ones. Thus
the correlation between severity of illness and insight appears
to be widely supported. Considering bipolar disorders and sub-
stance abuse from a unitary perspective, we propose the following
hypothesis: as to mood disorders, insight is absent in pure mania,
which, despite its dysfunctional aspects, is usually experienced by
patients as a pleasurable and rewarding experience; among heroin
addicts, insight seems to be impaired whenever heroin is enjoyed
without experiencing its destructive consequences on a social or
clinical plane. Insight into an experience might prove to be related
to the polarity of affect that is related to this experience (Cocores
et al., 1987; Maremmani et al., 2002, 2006, 2007a, 2009; Perugi
et al., 2002; Brousse et al., 2008; Maremmani, 2008; Pacini et al.,
2009; Pani et al., 2010).
In general, the level of patients’ insight has been reported to be
related to compliance with treatments and, as a result, with reten-
tion in treatment (Husted, 1999; Kao and Liu, 2010; Segarra et al.,
2010). Our results are consistent with a previous study by us, which
compared the retention in treatment of opioid-dependent subjects
with and without Axis-I psychiatric comorbidity. The absence of
differences between the two groups of patients in terms of reten-
tion in treatment, despite the higher methadone dose required for
clinical stabilization of dual diagnosis patients, support the present
observations indicating that a concomitant Axis-I disorder is not
responsible for lower levels of insight (Maremmani et al., 2000).
To sum up, among heroin addicts Axis-I comorbidity turns out
to play an opposite role, by comparison with other psychiatric
conditions, on levels of insight and retention rates. Even if further
studies are needed,we can speculate that the positive impact of psy-
chiatric comorbidity on insight levels might be mediated by the
therapeutic effect of methadone treatment on the psychopatho-
logical symptoms of psychiatric patients, and by the consequent
eventual improvement of their quality of life. These observations
are widely supported by the evidence in favor of the antidepres-
sant, anti-manic, stabilizing, antipsychotic, and anti-panic effects
of long-acting opioids (Spensley, 1976; Berger et al., 1980; Gerner
et al., 1980; Clouet, 1982; Exstein et al., 1982; Gold et al., 1982;
Varga et al., 1982; Emrich, 1984; Bodkin et al., 1995; Levinson
et al., 1995; Callaway, 1996; Krausz et al., 1996; Maremmani et al.,
1998, 2000; Pani et al., 1999).
In with-insight heroin addicts, at their treatment entry, stronger
lifetime concomitant substance abuse has been reported. This
observation is consistent not only with the evidence in favor
of greater severity in this kind of patient (Maremmani et al.,
2007b),but also with the higher rate of previous unsuccessful treat-
ments (especially short-term methadone treatments) that has been
recorded. Craving for alcohol and cocaine has, in fact, been found
to be correlated with low or non-blocking methadone dosages in
methadone-maintained patients (Stine et al., 1992; Tennant and
Shannon, 1995; Foltin and Fischman, 1996; Lubrano et al., 2002).
The fact that abuse modalities such as being junkies or two
worlders with a multi-daily and multi-weekly heroin intake have
also shown a positive correlation with a patient’s level of insight
is consistent with the trend observed for other clinical features
related to severity of illness. Stable heroin addicts, on the other
hand, might be expected to present low levels of insight by virtue
of their being more socially integrated, and exempt from any of
the major negative consequences of heroin addiction.
On the topic of therapeutic interventions, previous short-
term methadone treatments, psychotherapy, a concomitant psy-
chopharmacology treatment, and a previous therapeutic commu-
nity experience are features that have been reported in with-insight
heroin addicts. A history of unsuccessful treatments may act as a
factor promoting the development of higher levels of insight. If
patients are incapable of breaking away from heroin despite vari-
ous attempts to do so, they may well start to suspect that success
is not only a matter of being armed with “good intentions.”
CLINICAL IMPLICATIONS
Looking at the addiction history of our patients, we could say that
the level of insight seems to improve lately, with the progression of
the illness. In clinical practice it is frequent to have heroin addicts
at the earlier stages of their disease that did not want to start long-
acting opioid treatment, not only because they did not believe
to have a problem related to substance abuse, but also because
they are convinced that the choice to quit with heroin is merely
based on their “willpower”. On the other hand, it is also frequent
to observe heroin addicts that came to clinical setting looking for
any kind of help when they are in the last stages of addiction. In
these conditions, heroin addicts, who, like in our sample, luckily
present a better awareness of illness, are frequently junkies or two
worlders with multi-daily heroin intake, present previously unsuc-
cessful treatments and have a dual diagnosis, presenting a mental
illness, frequently belonged to the bipolar spectrum, that could
be related to their addiction history (Maremmani et al., 2011).
In other words insight came in the end and its presence correlate
with a more severe clinical presentation. Thus, clinicians have the
duty to improve the motivation to treatment in heroin addicts,
especially in the first phases of addiction in which patients still
did not show insight of illness and present a less severe clinical
presentation.
LIMITATIONS
Obvious limitations on this study include the fact that we are
reporting on a retrospective analysis carried out on a large cohort
of patients; it was not a study specifically designed to elucidate this
issue. The division of patients in to low and high insight groups
was based on their perceptions of the importance and severity of
their opioid abuse. Generally speaking, those with greater insight
were more attuned to the importance of their illness, yet it may
also be fair to simply hypothesize that the more severe an illness is,
the more likely someone is to develop an awareness of its impor-
tance. This may not, however, amount to any precise achievement
of “insight” in the usual psychological sense. In addition our tool
may not really measure insight but might show the awareness of
negative life situations.
In the literature, drug abuse and other psychiatric conditions
have been associated with a fall in the neural response to errors, in
those cortical regions that are thought to be critical to error pro-
cessing. This cognitive dysfunction has the potential to contribute
to the persistence of drug abuse, but has not been adequately
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targeted by our evaluation of these patients’ level of insight into
their illness (Hester et al., 2009). Some measure of insight as a
psychological variable independent of patients’ awareness of how
severe of their disease was would have strengthened this study.
In the future, an assessment of this kind may be employed in
identifying the high vs. low insight groups.
CONCLUSION
In conclusion, the awareness of illness often appears to be absent
in heroin addicts, as this situation can be found in a wide
range of psychiatric conditions. Compared with the impaired-
insight patients, those who possessed insight into their heroin
abuse behavior had gone further in their addictive career, showed
significantly greater awareness of past social, somatic, and psy-
chopathological impairments, and had experienced a greater num-
ber of past treatment-seeking events for heroin addiction. In
contrast with other psychiatric illnesses, the presence of awareness
appears to be related to the passing of time and the worsen-
ing of the illness. From a clinical point of view, methodologies
to improve the insight of patients should, therefore, be targeted
more directly on patients early in their history of heroin depen-
dence, because the risk of lack of insight is greatest during this
period.
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